
Frontiers in Pediatrics, Journal Year: 2025, Volume and Issue: 13
Published: April 25, 2025
Recent advancements in biomarker identification and machine learning have significantly enhanced the prediction diagnosis of Bronchopulmonary Dysplasia (BPD) neonatal respiratory distress syndrome (nRDS) preterm infants. Key predictors BPD severity include elevated cytokines like Interleukin-6 (IL-6) Tumor Necrosis Factor-alpha (TNF-α), as well inflammatory markers such Neutrophil-to-Lymphocyte Ratio (NLR) soluble gp130. Research into endoplasmic reticulum stress-related genes, differentially expressed ferroptosis-related genes provides valuable insights BPD's pathophysiology. Machine models XGBoost Random Forest identified important biomarkers, including CYYR1, GALNT14, OLAH, improving diagnostic accuracy. Additionally, a five-gene transcriptomic signature shows promise for early at-risk neonates, underscoring significance immune response factors BPD. For nRDS, biomarkers lecithin/sphingomyelin (L/S) ratio oxidative stress indicators been effectively used innovative methods, attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) high-content screening ABCA3 modulation. algorithms Partial Least Squares Regression (PLSR) C5.0 shown potential accurately identifying critical health indicators. Furthermore, advanced feature extraction methods analyzing cry signals offer non-invasive means to differentiate between conditions sepsis nRDS. Overall, these findings emphasize importance combining analysis with computational techniques improve clinical decision-making intervention strategies managing nRDS vulnerable
Language: Английский